$Strategy(MSTR)$ is back on track! Solid rebound underway with Bitcoin momentum building. Future looks bright, and perfect timing with the contra688 offer - free cash boost to load up. Ready for takeoff!

$Canaan Inc.(CAN)$ is more than just bitcoin mining! Its strategic push into AIoT and AI chips, coupled with solid supply chain control, is a game-changer. This fundamental transformation is unlocking real value—one to watch closely.

$Upstart Holdings, Inc.(UPST)$ its obvious insiders have let out bad earnings ..they knownby now as its lagged and theyre telling all their firends...and thisnstock isnstuck until theneconomy irons itslef out..thayll take like 3 or 5 years.

$Walt Disney(DIS)$ Such a cheap stock even at $160. Pre-pandemic the parks/core business did $7-8 EPS so you are paying a reasonable multiple for a classic franchise and you get the stream business for free. Stock should be at $200 by year-end. BULLISH

$Alphabet(GOOGL)$ at $225 now. A true long-term play! Its AI roadmap is the clearest, backed by massive data and a "Do the right thing" ethos. This edge is just huge.

$Elevai Labs, Inc.(ELAB)$ Elevai Labs (ELAB) announce it has signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio (INMB). The licensing agreement grants Elevai a license to use INmune Bio's proprietary "EMx" technology, developed by INmune Bio, Inc., CMO, Mark Lowdell, PhD, that enables Elevai to manufacture current Good Manufacturing Practice grade, human umbilical cord-derived mesenchymal stromal cells (hucMSCs) at a lower cost to Elevai than purchasing hucMSCs outright. Manufactured hucMSCs can be incorporated into certain licensed topical cosmetic products sold in the medical aesthetics skincare market.... They are seeking more expansion, and you know what it means...

NEVER FORGET! "A rising tide lifts all boats". - John F. Kennedy. $Bakkt Holdings, Inc.(BKKT)$ has been dead the entire month, not moving up, but selling down and look at it today! $Canaan Inc.(CAN)$ will have its turn too! I just keep stacking the dips. NFA.

$HubSpot(HUBS)$ reported Q1 revenue of $714M, up 15.7% YoY, with subscription revenue contributing over $698M，a strong signal of recurring growth. HubSpot continues to expand steadily in the CRM and marketing automation space, driven by product enhancements and a growing customer base. A solid SaaS player worth keeping on the radar.

NVDA’s earnings report has shown investors that NVDA is currently trading at a HUGE opportunistic discount and is way, WAY oversold at current trading price!🤔💰👌—- This is the time to start loading up at this Great NVDA Global sector leading business at this extreme bargain zone leading into it’s earnings report on February 16!!!🎯📈💪🚀 $NVIDIA Corp(NVDA)$

$UnitedHealth(UNH)$ and $Regeneron Pharmaceuticals(REGN)$ ’s recent moves show one thing: don’t bet too much on single stocks. In the U.S. market. Index investing is the safer path, with index enhancement being the real strategy to beat the market.